Skip to main content
Venrock

Venrock

Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock partners with entrepreneurs to build some of the world’s most disruptive, successful companies. With a primary focus on technology and healthcare, portfolio companies have included 10X Genomics, Apple Computer, AveXis, Check Point Software, CloudFlare, Dollar Shave Club, Gilead Sciences, Idec Pharma, Illumina, Intel, Millennium Pharma and Nest. For more information, please visit Venrock’s website at www.venrock.com and follow the firm on X at @venrock.www.venrock.com

Search complete. 17 mentions across 10 episodes found for "Venrock".

Oct 21, 2026

speaker_0NARRATOR
0:00
[upbeat music] Welcome to Running Through Walls, a Venrock podcast featuring conversations between investors and entrepreneurs.
speaker_0NARRATOR
0:12
Each episode, we offer a behind-the-scenes look at pivotal moments in time.
speaker_0NARRATOR
0:16
[upbeat music]
Marino GarciaGUEST
2:28
I had some experience in complement before, and I was a little stunned that nobody had ever thought of what you guys had before.
Marino GarciaGUEST
2:35
Second, it was the team, honestly.
Marino GarciaGUEST
2:37
Uh, meeting you and Andrew at Venrock, uh, Lonnie Mulder, the chairman, Tamas and Peter at Fairmount.
Marino GarciaGUEST
2:45
I was just really impressed with the people around it, and as I mentioned, people really do make a big difference, so I, I really wanted to work with this group of people.
Marino GarciaGUEST
2:54
And then the idea of just building something new, a new company.
Logan PlasterHOST
18:25
So you can find that in the app.
Logan PlasterHOST
18:27
And then after that, fireside chat with Venrock's Bob Kocher, and that's gonna be a great conversation, great w- way to meet an investor, ask your questions, get to understand their thesis, how they're thinking about investing right now.
Logan PlasterHOST
18:41
And this conversation can continue on the member app, so if you are unfamiliar with how to engage, get involved on the app.
Logan PlasterHOST
18:48
You can reach out to me or anybody else on the team, and we can help you out there.

Unknown podcast

Daily Briefing for October 14, 2026

Oct 14 · 1 Mention

speaker_0HOST
3:15
Who put the money in? And what's the growth story?
speaker_1HOST
3:18
New investors Healthier Capital, Crosslink Capital, and Hercules Capital, alongside existing backers including Venrock and Flare Capital Partners.
speaker_1HOST
3:27
Suki said revenue doubled in 2025, and patient encounters on its AI documentation tools grew more than one hundred and ninety percent year over year in 2026.
speaker_1HOST
3:37
It didn't disclose evaluation.
Ilya StrebulaevGUEST
2:26
That's been an amazing venture capital firm for, you know, thirty-plus years.
Ilya StrebulaevGUEST
2:30
Then, uh, there is Venrock, a venture capital firm that... storied one from the 1960s, and still, uh, very active today.
Ilya StrebulaevGUEST
2:38
Then there are venture capital firms that's been around maybe for twenty years.
Ilya StrebulaevGUEST
2:43
Uh, for example, Emergence Capital, that's specializing in B2B SaaS, or Andreessen Horowitz, also known as a16z, that is investing in a lot of stuff and of course, this day, is leading, I think, in, uh, the field of AI.
Ilya StrebulaevGUEST
3:17
That's been an amazing venture capital firm for, you know, 30-plus years.
Ilya StrebulaevGUEST
3:21
Then, uh, there is Venrock, a venture capital firm that... storied one from the 1960s, and still, uh, very active today.
Ilya StrebulaevGUEST
3:28
Then there are venture capital firms that's been around maybe for 20 years.
Ilya StrebulaevGUEST
3:33
Uh, for example, Emergence Capital, that's specializing in B2B SaaS, or Andreessen Horowitz, also known as a16z, that is investing in a lot of stuff and of course, this day, is leading, I think, in, uh, the field of AI.
Morgan HitzigGUEST
2:23
And I think the, the biggest thing there is just having seen kinda every, every step change that, that comes with a company's growth trajectory and just knowing kind of the blood, sweat, and tears that, that go into getting from zero to one million, one million to, to, to 10 and, and beyond from there.
Morgan HitzigGUEST
2:40
Um, and over the last couple of years have transitioned into to venture capital, uh, first at a firm called Venrock, which is an unbelievable story-
MattHOST
2:47
Unbelievable
Morgan HitzigGUEST
2:48
... venture firm.
Ron RexhaGUEST
17:51
yet?Yeah, great question.
Ron RexhaGUEST
17:53
I mean, look, we've been incredibly lucky and, and fortunate and, and grateful to all of our investors from General Catalyst to Venrock to Index, and as well as some of the great folks on, on our board and advisory group that have really advised me in kind of thinking about how to navigate this industry and be able to scale.
Ron RexhaGUEST
18:09
But then, um, additionally, incredibly grateful to our advisors and our team that we've been able to, like, partner with and, and help serve a lot of the clients and client relationships that they've built for, you know, a long time.
Ron RexhaGUEST
18:21
Um, and I think at the same time, being able to, um, build an incredible platform with, you know, really, really top-tier talent, um, in New York coming from companies like Plaid, Stripe, Ramp, Rippling, like you name it, um, just has enabled us to show and create that value so quickly that thus has kind of like, you know, um, resulted in our ability to scale our assets both on like by attracting advisors, but then also on the client side, um, as well.
Unity StoakesHOST
1:39
He helped shape national healthcare policy during the Obama administration, helping architect the ACA, in fact.
Unity StoakesHOST
1:47
He spent years at McKinsey, trained and still practices today as a physician, and really today is one of the world's great healthcare investors as a partner at Venrock, where he's backed and helped build some of the most important companies in healthcare, including Devoted Health and Virta Health, companies we're very proud to have invested in at StartUp Health.
Unity StoakesHOST
2:13
So today is really our opportunity to learn from Bob and we hope, as always, you post your questions in the chat.
Unity StoakesHOST
2:23
After Bob and I have a conversation, we'll open it up for questions.

16 MINS LATER

Unity StoakesHOST
18:36
And, you know, obviously things have evolved a lot from seed and A from when you started to, to today.
Unity StoakesHOST
18:45
What, what do you think founders really need to have proven today that might have been different from years past where you really need to show up with, with more today?
Bob KocherGUEST
18:58
Well, certainly on the have, have more software built at the beginning because when we were seeding things when you and I were starting StartUp Health and I joined Venrock, we were looking at, you know, screenshots on a PowerPoint of like what our product might look like.
Bob KocherGUEST
19:13
And then they'd be like, "You invest the money and give me a year and I'll build the thing that you looked at on this PowerPoint." Today people can arrive with prototypes of the product and ideally they've had customers try it and give it feedback and so you're not limited so much by a very hard to build software product.
Jason WenkGUEST
41:09
So knowing all that going in, I wanted to find the right type of investors who would think in decades and not necessarily think in terms of like, well, this is a little seed roll of the dice and hopefully this lasts for a year and we can attract a second investor.
Jason WenkGUEST
41:24
So my first investor was Nick Bimes from Venrock.
Jason WenkGUEST
41:28
And Fedrock is the, you know, the name is kind of gives away, but it's a Rockefeller family's venture fund that they started back in the 1960s.
Jason WenkGUEST
41:35
They were the first ever investor in Apple Computer and a whole bunch of other legendary companies.
Jason WenkGUEST
42:05
They are who introduced me to a guy named Bill McNabb.
Jason WenkGUEST
42:09
Bill was the former chairman and CEO of Vanguard.
Jason WenkGUEST
42:12
And Bill was on the board of United Healthcare, which is one of the other Venrock partners was also on that board.
Jason WenkGUEST
42:18
And so that's kind of how we made this, you know, two degrees of separation kind of connection there.
Morgan HitzigGUEST
2:41
And he was right.
Morgan HitzigGUEST
2:42
So I joined Venrock for a couple of years, learned from the best of the best.
Morgan HitzigGUEST
2:48
And now at Overmatch, we're very focused on deep tech defense in space, which is where my passion has really been for the entirety of my career.
David GraffHOST
2:56
Awesome.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.